(131)I-labeled metuximab combined with chemoembolization for unresectable hepatocellular carcinoma

AIM: To investigate the safety and effectiveness of combined (131)I-metuximab and transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC). METHODS: One hundred and eighty-five patients (159 men and 26 women) with advanced HCC were enrolled in this study from February 2009...

Full description

Saved in:
Bibliographic Details
Main Authors: He, Qing, Lu, Wu-Sheng, Liu, Yang, Guan, Yong-Song, Kuang, An-Ren
Format: Artigo
Language:Inglês
Published: Baishideng Publishing Group Co., Limited 2013
Subjects:
Brief Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3870565/
https://ncbi.nlm.nih.gov/pubmed/24379637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v19.i47.9104
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items